Judit Végh

657 total citations
25 papers, 456 citations indexed

About

Judit Végh is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Judit Végh has authored 25 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Rheumatology. Recurrent topics in Judit Végh's work include Systemic Sclerosis and Related Diseases (11 papers), Systemic Lupus Erythematosus Research (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Judit Végh is often cited by papers focused on Systemic Sclerosis and Related Diseases (11 papers), Systemic Lupus Erythematosus Research (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Judit Végh collaborates with scholars based in Hungary, Norway and Ireland. Judit Végh's co-authors include Péter Szodoray, E. Bodolay, István Csípő, G. Szegedi, Zoltán Szekanecz, Margit Zeher, Katalin Dévényi, Pál Soltész, László Galuska and Edit Bodolay and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Judit Végh

25 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judit Végh Hungary 12 226 171 155 129 94 25 456
Geetabali Sircar India 11 234 1.0× 171 1.0× 144 0.9× 136 1.1× 146 1.6× 20 437
Alice Ballerie France 13 231 1.0× 197 1.2× 60 0.4× 132 1.0× 114 1.2× 29 481
Mei Huang China 11 114 0.5× 192 1.1× 109 0.7× 81 0.6× 149 1.6× 36 435
E L Nassonov Russia 10 105 0.5× 51 0.3× 100 0.6× 93 0.7× 48 0.5× 22 315
B. Mascagni Italy 8 249 1.1× 69 0.4× 57 0.4× 114 0.9× 33 0.4× 10 316
Michela Pinnelli Italy 8 111 0.5× 50 0.3× 49 0.3× 216 1.7× 140 1.5× 8 437
Magdalena Dryglewska Poland 12 107 0.5× 36 0.2× 144 0.9× 68 0.5× 137 1.5× 36 359
Rossana Faedda Italy 11 62 0.3× 92 0.5× 84 0.5× 67 0.5× 38 0.4× 23 444
Henrietta Dér Hungary 9 140 0.6× 31 0.2× 234 1.5× 228 1.8× 74 0.8× 12 466
C. Cazalets France 14 196 0.9× 161 0.9× 36 0.2× 50 0.4× 119 1.3× 38 445

Countries citing papers authored by Judit Végh

Since Specialization
Citations

This map shows the geographic impact of Judit Végh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Végh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Végh more than expected).

Fields of papers citing papers by Judit Végh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Végh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Végh. The network helps show where Judit Végh may publish in the future.

Co-authorship network of co-authors of Judit Végh

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Végh. A scholar is included among the top collaborators of Judit Végh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Végh. Judit Végh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papp, Gábor, Ildikó Fanny Horváth, Edit Gyimesi, et al.. (2015). The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study. Immunologic Research. 64(2). 404–411. 11 indexed citations
2.
Tímár, Orsolya, Zoltán Szekanecz, György Kerekes, et al.. (2012). THU0240 Rosuvastatin improves impaired endothelial function and lowers high sensitivity CRP in patients with systemic sclerosis – a prospective case-series study. Annals of the Rheumatic Diseases. 71. 236–236. 1 indexed citations
3.
Szodoray, Péter, Ágota Hajas, László Kardos, et al.. (2012). Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus. 21(13). 1412–1422. 59 indexed citations
4.
Zeher, Margit, Gábor Papp, Sándor Baráth, et al.. (2012). 348 Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis. World Allergy Organization Journal. 5. S112–S112. 1 indexed citations
5.
Galajda, Zoltán, et al.. (2012). Cardiac manifestations in a young man with Takayasu arteritis associated with antiphospholipid syndrome.. PubMed. 14(12). 768–70. 3 indexed citations
6.
Zeher, Margit, et al.. (2012). [Systemic sclerosis in a patient suffering from breast cancer].. PubMed. 56(1). 50–4. 1 indexed citations
7.
Papp, Gábor, Ildikó Fanny Horváth, Sándor Baráth, et al.. (2011). Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis. Clinical Immunology. 142(2). 150–159. 42 indexed citations
8.
Szodoray, Péter, Zoltán Szöllősi, Edit Gyimesi, et al.. (2008). Sarcoidosis in patients with mixed connective tissue disease: clinical, genetic, serological and histological observations. Rheumatology International. 28(8). 743–747. 7 indexed citations
9.
Bodolay, Edit, I. Serés, Péter Szodoray, et al.. (2008). Evaluation of paraoxonase activity in patients with mixed connective tissue disease.. PubMed. 35(2). 237–43. 18 indexed citations
10.
Miltényi, Zsófia, et al.. (2007). What is the Price of survival in Hodgkin's lymphoma? Long‐term follow‐up of cured patients. Hematological Oncology. 25(4). 178–183. 6 indexed citations
11.
Végh, Judit, et al.. (2006). Diastolic function of the heart in mixed connective tissue disease. Clinical Rheumatology. 26(2). 176–181. 11 indexed citations
12.
Végh, Judit, Péter Szodoray, János Kappelmayer, et al.. (2006). Clinical and Immunoserological Characteristics of Mixed Connective Tissue Disease Associated with Pulmonary Arterial Hypertension. Scandinavian Journal of Immunology. 64(1). 69–76. 40 indexed citations
13.
Baráth, S., Sándor Sipka, Magdolna Aleksza, et al.. (2006). Regulatory T cells in peripheral blood of patients with mixed connective tissue disease. Scandinavian Journal of Rheumatology. 35(4). 300–304. 21 indexed citations
14.
Végh, Judit, István Csípő, Gabriella Lakos, et al.. (2006). Clinical and immunoserological characteristics of mixed connective tissue disease (MCTD) associated with pulmonary arterial hypertension (PAH). 5(2). 37–48. 3 indexed citations
15.
Bodolay, E., Zoltán Szekanecz, Katalin Dévényi, et al.. (2005). Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Lara D. Veeken. 44(5). 656–661. 99 indexed citations
16.
Végh, Judit, Györgyike Soós, István Csípő, et al.. (2005). Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost. Rheumatology International. 26(3). 264–269. 14 indexed citations
17.
Bodolay, E., Zoltán Szekanecz, Judit Végh, & G. Szegedi. (2005). Mixed connective tissue disease: should the diagnosis be more restrictive?: reply. Lara D. Veeken. 44(11). 1466–1467. 1 indexed citations
18.
Bodolay, Edit, Judit Végh, Pál Soltész, et al.. (2002). [Evaluation of survival in mixed connective tissue disease (MCTD)].. PubMed. 143(45). 2543–8. 6 indexed citations
19.
Soltész, Pál, Judit Végh, Gabriella Lakos, et al.. (2000). Catastrophic antiphospholipid syndrome in cancer. PubMed. 30(4). 303–311. 19 indexed citations
20.
Soltész, Pál, Zoltán Szekanecz, Judit Végh, et al.. (1999). [Catastrophic antiphospholipid antibody syndrome in a cancer patient].. PubMed. 140(52). 2917–20. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geetabali Sircar Breakdown of academic impact, for papers by Alice Ballerie Breakdown of academic impact, for papers by Mei Huang Breakdown of academic impact, for papers by E L Nassonov Breakdown of academic impact, for papers by B. Mascagni Breakdown of academic impact, for papers by Michela Pinnelli Breakdown of academic impact, for papers by Magdalena Dryglewska Breakdown of academic impact, for papers by Rossana Faedda Breakdown of academic impact, for papers by Henrietta Dér Breakdown of academic impact, for papers by C. Cazalets
Rankless by CCL
2026